Navigation Links
Coloplast Delivers On Ambitious Targets With Solid Interim Report
Date:8/13/2014

MINNEAPOLIS, Aug. 13, 2014 /PRNewswire/ -- Danish medical device company Coloplast delivered revenue of USD* 1,654 million (DKK 9,214 million) and 9% organic growth in the first nine months of the 2013/14 financial year. Q3 organic growth was 8%.

EBIT before special items was up by 13% to USD 547 million (DKK 3,047 million). The EBIT margin before special items was 33% against 31% in 9M 2012/13.

Delivering on ambitious targets
"I'm pleased with the solid financial results we are announcing today. We are continuing our string of healthy growth in all business areas and in all regions, and our consolidated profit is matching the high expectations we have for our company," said Coloplast CEO Lars Rasmussen.

Global sales growth by business area was as follows: Ostomy Care 8%, Continence Care 11%, Urology Care 10% and Wound & Skin Care 10%. Coloplast grew its European business by 6%, Other Developed Markets by 10% and Emerging Markets by 24%.

Consumer centered strategy
Senior Vice President, Chronic Care US, Ed Veome says: "The US is an important market for Coloplast and we have invested to grow our business as we see great potential. It is very encouraging that we have seen strong sales performance in our continence and ostomy care product lines."

"We're pursuing a strategy that puts the consumer in the center. The majority of our users in the US have overcome critical conditions that led them to our products, and we want to help them return to their normal lives. We can only do that by listening and responding to their needs."

Coloplast employs more than 500 people in the US and has it US headquarter in Minneapolis, Minnesota. Globally Coloplast employs more than 9.000 with its products being sold in more than 100 countries around the world. Coloplast is listed on the Copenhagen Stock Exchange, part of the NASDAQ OMX Group and has a market cap of around USD 18 billion (DKK 100 billion).

Financial guidance for 2013/14 unchanged
Following the Q3 interim report, Coloplast continues to expect full-year organic revenue growth of about 9% and of about 7% in DKK. The company continues to expect the EBIT margin before special items to be 33-34% at constant exchange rates and about 33% in DKK.

For further information, click here to read the Q3 Interim Report.

*At exchange rate USD/DKK 5,57

www.coloplast.com Financial highlights and key ratios Financial highlights
and key ratios
DKKm9M
2013/149M
2012/13ChangeFY 2012/13Revenue

9,214

8,665

6%

11,635EBIT

2,047

2,699

(24%)

3,672EBIT margin

22%

31%

(9) p.p.

32%Special items

1,000

-

-

-EBIT before special items

3,047

2,699

13%

3,672EBIT margin before special items

33 %

31%

2 p.p.

32%Sales performance by
business area 9M
2013/14
DKKm9M
2012/13
DKKmOrganic growthReported growthOstomy Care

3,764

3,613

8%

4%Continence Care

3,288

3,029

11%

9%Urology Care

898

844

10%

6%Wound & Skin Care

1,264

1,179

10%

7%Revenue9,214

8,665

9%

6%Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ more than 9,000 people.


'/>"/>
SOURCE Coloplast
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
2. First Paralyzed Formula Race Car Drivers "Road to Indy" Sponsored By Coloplast
3. Coloplast Launches the Innovative Altis Single Incision Sling System
4. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
5. Direct Relief Delivers Hurricane Packs As FEMA Urges Preparedness
6. Bayer Partnership Delivers Industry-First Dose Management Offering
7. Largest Public Hospital in Sydney Delivers First Treatment in Australia Using Advanced TrueBeam Radiotherapy and Radiosurgery Device
8. MIOT Hospital Delivers First TrueBeam STx Radiotherapy Treatment in Chennai
9. New Fluke intrinsically safe digital multimeter delivers extreme ruggedness for use in potentially explosive environments
10. Del Mar CEO Delivers Keynote Address at International Drug Discovery Science and Technology Conference
11. Cloudnine Group of Hospitals Delivers 12 Babies by Mid-day on 12/12/12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... VEGAS , June 26, 2016 ... to value-based care operating models within the health care ... enable greater financial efficiency , Deloitte offers a ... the key business issues impacting efficient cost optimization: labor ... , These services facilitate better outcomes and better ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):